Advaxis and Sellas Life Sciences Group, two companies that have pursued different ways of prompting the body’s immune system to fight cancer, are now hoping that combining their efforts will lead to a more precise treatment. The agreement between the companies calls for Princeton, NJ-based Advaxis (NASDAQ: ADXS) to license to Sellas its technology for […]
What Our Clients Say
[ssba_hide]
[testimonials category="Testimonial" random=true limit="1"]
Press Releases and Whitepapers
Industry News & Articles
- Jeff Bezos is reportedly courting Trump after public spat with Musk
- People use AI for companionship much less than we’re led to think
- Brad Feld on “Give First” and the art of mentorship (at any age)
- Sam Altman comes out swinging at The New York Times
- Kalshi closes $185M round as rival Polymarket reportedly seeks $200M
- Air quality tests around xAI’s Memphis data center raise questions
- Creative Commons debuts CC signals, a framework for an open AI ecosystem
- Meta is adding AI-powered summaries to WhatsApp
Sample Relationships
[logo-carousel id=relationships]
Notables
[logo-carousel id=notables]